NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy.
Overview
- Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA; (N.G.-K.)
- Parkinson’s Disease Research Education and Clinical Care, Center (PADRECC), VA Portland Healthcare System, Portland, OR 97239, USA
Abstract
Parkinson’s Disease (PD) is the second most diagnosed neurological disorder globally, affecting millions of people worldwide. Oxidative stress is implicated in the progression of PD, yet its direct effects on motor function, particularly in the context of synucleinopathy, are not fully understood. Here, we investigated the effects of the loss of the antioxidant regulatory transcription factor NRF2 in the A53TSyn mouse model of synucleinopathy. Motor function was evaluated in separate cohorts of A53TSyn mice without NRF2 (A53TSyn/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- doi:10.5061/
dryad.vmcvdnd7x , at Dryad; found in DataCite
Data Availability Statement
The raw data supporting the conclusions of this article will be madeavailable by the authors on request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 10 keywords, 1 funder, 40 references.
Cite
This paper
Gladen-Kolarsky, N., Kuhnau, L., Hack, W., Quinn, J. F., & Gray, N. E. (2026). NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy. Antioxidants (Basel, Switzerland), 15(8), 926. https://
BibTeX
@article{gladenkolarsky2
author = {Gladen-Kolarsky, Noah and Kuhnau, Lucas and Hack, Wyatt and Quinn, Joseph F and Gray, Nora E},
title = {{NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy}},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
month = jul,
volume = {15},
number = {8},
pages = {926},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2076-3921},
doi = {10.3390/
url = {https://
pmid = {42650189},
pmcid = {PMC13509511}
}
RIS
TY - JOUR
AU - Gladen-Kolarsky, Noah
AU - Kuhnau, Lucas
AU - Hack, Wyatt
AU - Quinn, Joseph F
AU - Gray, Nora E
TI - NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy
T2 - Antioxidants (Basel, Switzerland)
J2 - Antioxidants (Basel)
PY - 2026
DA - 2026/
VL - 15
IS - 8
SP - 926
SN - 2076-3921
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3390/
"type": "article-journal",
"title": "NRF2 Deletion Results in Mobility Impairment in A53TSyn Model of Synucleinopathy",
"container-title": "Antioxidants (Basel, Switzerland)",
"author": [
{
"family": "Gladen-Kolarsky",
"given": "Noah"
},
{
"family": "Kuhnau",
"given": "Lucas"
},
{
"family": "Hack",
"given": "Wyatt"
},
{
"family": "Quinn",
"given": "Joseph F"
},
{
"family": "Gray",
"given": "Nora E"
}
],
"container-title-short":
"volume": "15",
"issue": "8",
"page": "926",
"DOI": "10.3390/
"PMID": "42650189",
"PMCID": "PMC13509511",
"ISSN": "2076-3921",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
25
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s12974-025-03455-x
- Repurposing of epalrestat for neuroprotection in parkinson's disease via activation of the KEAP1/
Nrf2 pathway. Journal: Journal of neuroinflammationIn common: Parkinson's, mouse, cellular / molecular, 4 references - [2] doi:10.1002/ctm2.70420
- YOD1 regulates oxidative damage of dopamine neurons in Parkinson's disease by deubiquitinating PKM2.Journal: Clinical and translational medicineIn common: Parkinson's, mouse, cellular / molecular, 4 references
- [3] doi:10.1038/s41531-024-00763-6
- Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers.Journal: NPJ Parkinson's diseaseIn common: Parkinson's, 3 references
- [4] doi:10.1186/s12974-023-02776-z
- PARK7/
DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target. Journal: Journal of neuroinflammationIn common: Parkinson's, cellular / molecular, 3 references - [5] doi:10.1002/jev2.12397
- Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies.Journal: Journal of extracellular vesiclesIn common: cellular / molecular, author Joseph F Quinn
- [6] doi:10.1038/s41531-024-00697-z
- GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults.Journal: NPJ Parkinson's diseaseIn common: Parkinson's, mouse, cellular / molecular, 2 references
- [7] doi:10.1177/0271678x251338952
- Neural and vascular contributions to sensory impairments in a human alpha-synuclein transgenic mouse model of Parkinson's disease.Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and MetabolismIn common: Parkinson's, mouse, cellular / molecular, 2 references
- [8] doi:10.1038/s41467-023-42876-1
- Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model.Journal: Nature communicationsIn common: Parkinson's, mouse, cellular / molecular, 2 references
- [9] doi:10.1038/s44328-025-00057-8
- Organic electrolyte gated field effect transistor for detecting alpha synuclein longitudinally in Parkinsonism mouse model.Journal: Npj biosensingIn common: Parkinson's, mouse, 2 references
- [10] doi:10.1038/s41531-022-00282-2
- Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures.Journal: NPJ Parkinson's diseaseIn common: Parkinson's, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
